Versarien plc isn’t the only growth stock that could make you a million

G A Chester discusses the valuation of Versarien plc (LON:VRS) and another small-cap with stunning growth prospects.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shares of graphene specialist Versarien (LSE: VRS) have soared 390% over the last 12 months. But before discussing the current valuation and prospects of this hot growth stock, I’d like to tell you about another high-flying small-cap, Tarsus (LSE: TRS). This international business-to-business media group reported stunning top- and bottom-line growth in its annual results today.

Strong underlying growth

Tarsus is growing strongly, both organically and through carefully targeted acquisitions, intent on maximising the scale of its exhibitions and conferences and deepening its presence in higher-growth markets. A record year in 2017 saw revenue of £118m — 72% ahead of 2016 — and an 82% rise in underlying earnings per share (EPS) to 27.7p.

The current share price is 306p (little changed on the day), valuing this FTSE SmallCap-listed company at £346m. The price-to-sales (P/S) ratio is 2.9, the price-to-earnings (P/E) ratio is 11 and there’s also a 3.3% dividend yield, with the board having declared a 10p a share payout.

Tarsus has an up-and-down annual EPS profile, which is off-putting at first sight. However, this cycle is because not all its events are annual. The table below, showing EPS growth year-on-year and year-on-year-after, gives an understanding of the progress the company’s making.

  2013 2014 2015 2016 2017 2018 est.
EPS 20.0p 12.7p 21.4p 15.2p 27.7p 17.9p
Growth year-on-year +64% -37% +69% -29% +82% -35%
Growth year-on-year-after +18% +4% +7% +20% +29% +18%

I’m not concerned by Tarsus’s lumpy year-on-year earnings. The bottom line of the table shows the strong underlying growth and I rate the stock a ‘buy’.

Price to sales

I had a close look at Versarien just before Christmas. I found no glaring ‘red flags’ in this AIM-listed company’s accounts or in its directors’ backgrounds. Its history of acquisitions wasn’t altogether impressive but I concluded that two key acquisitions in the graphene space represented a genuinely significant commercial opportunity.

My personal rule of thumb is that however promising a company may be, the maximum P/S I’d be willing to buy at is 10. In Versarien’s case this resulted in a buy price of up to 59p, based on annualising its £4.38m revenue in the six months to 30 September.

Progress

Having missed a chance when the shares dipped into my ‘buy’ territory early in the New Year and with a good bit of news flow from the company since, how does the land lie today?

So far this year, Versarien has announced an agreement with an unnamed Asia-headquartered global textiles and apparel manufacturer, a medical technology collaboration and another with minimalist footwear maker Vivobarefoot. As with similar announcements in the latter part of last year, it has given no indication of future revenues. Nor have we had an update on actual revenue booked since the 30 September half-year-end.

Price target

I can still find no broker forecasts, which leaves me with my valuation based on annualised H1 revenue. However, with the news flow and the year-end approaching, I’m now inclined to calculate revenue more generously by applying the H1 growth rate to the full year. This results in a figure of £9.95m.

So on my maximum P/S of 10, I’d only rate Versarien a ‘buy’ with its market capitalisation at up to £99.5m — currently represented by a share price of 67p. With the shares trading at 85p as I’m writing, I may live to rue missing that sub-59p opportunity at the start of the year.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any of the shares mentioned. The Motley Fool UK has recommended Tarsus Group. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »

Investing Articles

Are HSBC shares a FTSE bargain? Here’s what the charts say!

There are plenty of dirt-cheap FTSE 100 banking stocks for investors to choose from today. Our writer Royston Wild believes…

Read more »